Nagel JH - Search Results

1

BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants.

Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M. Elstrodt F, et al. Among authors: nagel jh. Cancer Res. 2006 Jan 1;66(1):41-5. doi: 10.1158/0008-5472.CAN-05-2853. Cancer Res. 2006. PMID: 16397213

2

Exon expression arrays as a tool to identify new cancer genes.

Schutte M, Elstrodt F, Bralten LB, Nagel JH, Duijm E, Hollestelle A, Vuerhard MJ, Wasielewski M, Peeters JK, van der Spek P, Sillevis Smitt PA, French PJ. Schutte M, et al. Among authors: nagel jh. PLoS One. 2007 Aug 20;3(8):e3007. doi: 10.1371/journal.pone.0003007. PLoS One. 2007. PMID: 18688287 Free PMC article.

3

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.

Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M, Ng SS, French PJ, Peeters JK, Rozendaal MJ, Riaz M, Koopman DG, Ten Hagen TL, de Leeuw BH, Zwarthoff EC, Teunisse A, van der Spek PJ, Klijn JG, Dinjens WN, Ethier SP, Clevers H, Jochemsen AG, den Bakker MA, Foekens JA, Martens JW, Schutte M. Hollestelle A, et al. Among authors: nagel jh. Breast Cancer Res Treat. 2010 May;121(1):53-64. doi: 10.1007/s10549-009-0460-8. Epub 2009 Jul 11. Breast Cancer Res Treat. 2010. PMID: 19593635

4

Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes.

Nagel JH, Peeters JK, Smid M, Sieuwerts AM, Wasielewski M, de Weerd V, Trapman-Jansen AM, van den Ouweland A, Brüggenwirth H, van I Jcken WF, Klijn JG, van der Spek PJ, Foekens JA, Martens JW, Schutte M, Meijers-Heijboer H. Nagel JH, et al. Breast Cancer Res Treat. 2012 Apr;132(2):439-48. doi: 10.1007/s10549-011-1588-x. Epub 2011 May 26. Breast Cancer Res Treat. 2012. PMID: 21614566

5

MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.

Wasielewski M, Nagel JH, Brekelmans C, Klijn JG, van den Ouweland A, Meijers-Heijboer H, Schutte M. Wasielewski M, et al. Among authors: nagel jh. Breast Cancer Res Treat. 2007 Aug;104(2):153-7. doi: 10.1007/s10549-006-9407-5. Epub 2006 Nov 2. Breast Cancer Res Treat. 2007. PMID: 17080308

6

Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines.

Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW, Schutte M. Hollestelle A, et al. Among authors: nagel jh. Mol Cancer Res. 2007 Feb;5(2):195-201. doi: 10.1158/1541-7786.MCR-06-0263. Mol Cancer Res. 2007. PMID: 17314276 Free article.

7

Gene expression profiles associated with treatment response in oligodendrogliomas.

French PJ, Swagemakers SM, Nagel JH, Kouwenhoven MC, Brouwer E, van der Spek P, Luider TM, Kros JM, van den Bent MJ, Sillevis Smitt PA. French PJ, et al. Among authors: nagel jh. Cancer Res. 2005 Dec 15;65(24):11335-44. doi: 10.1158/0008-5472.CAN-05-1886. Cancer Res. 2005. PMID: 16357140

8

Structural parameters affecting the kinetics of RNA hairpin formation.

Nagel JH, Flamm C, Hofacker IL, Franke K, de Smit MH, Schuster P, Pleij CW. Nagel JH, et al. Nucleic Acids Res. 2006 Jul 19;34(12):3568-76. doi: 10.1093/nar/gkl445. Print 2006. Nucleic Acids Res. 2006. PMID: 16855293 Free PMC article.

9

Self-induced structural switches in RNA.

Nagel JH, Pleij CW. Nagel JH, et al. Biochimie. 2002 Sep;84(9):913-23. doi: 10.1016/s0300-9084(02)01448-7. Biochimie. 2002. PMID: 12458084 Review.

10

A pH-jump approach for investigating secondary structure refolding kinetics in RNA.

Nagel JH, Gultyaev AP, Oistämö KJ, Gerdes K, Pleij CW. Nagel JH, et al. Nucleic Acids Res. 2002 Jul 1;30(13):e63. doi: 10.1093/nar/gnf057. Nucleic Acids Res. 2002. PMID: 12087188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page